Literature DB >> 15787979

Experiments to optimize enzyme substitution therapy in pancreatic duct-ligated pigs.

E Kammlott1, J Karthoff, K Stemme, P Gregory, J Kamphues.   

Abstract

Ligation of the pancreatic duct in pigs leads to severe maldigestion and malabsorption of crude nutrients. Supplementation with 24 capsules of Creon (Solvay Pharmaceuticals GmbH, Hannover, Germany) per meal led to an increased digestibility of crude nutrients. With regard to optimization of the treatment of EPI no essential improvements can be achieved by adding omeprazol or lecithin to the diet. In pancreatic duct-ligated pigs the isolated addition of omeprazol led to an increase of the pre-caecal digestibility of crude fat and organic matter. With additional enzyme substitution, the application of omeprazol did not result in an improved fat digestibility. Isolated addition of lecithin to the diet resulted in a reduced total digestibility of crude fat. Offering the diet twice a day and using a higher frequency of enzyme applications (four or six instead of only two applications) had no effects on the digestibilty of crude fat or organic matter. According to the observations in pancreatic duct-ligated pigs, the addition of missing enzymes to the diet led to the best treatment results in EPI. Administration of omeprazol or a higher feeding frequency as well as the application of enzymes in small proportion of the whole meal or dosages given consecutively over the day showed no advantages. Furthermore, the present study suggests that the addition of lecithin cannot be recommended in EPI, when given diets with butter as the predominant fat source as in human dietetics.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15787979     DOI: 10.1111/j.1439-0396.2005.00545.x

Source DB:  PubMed          Journal:  J Anim Physiol Anim Nutr (Berl)        ISSN: 0931-2439            Impact factor:   2.130


  6 in total

1.  Starch Origin and Thermal Processing Affect Starch Digestion in a Minipig Model of Pancreatic Exocrine Insufficiency.

Authors:  Anne Mößeler; Sandra Vagt; Martin Beyerbach; Josef Kamphues
Journal:  Gastroenterol Res Pract       Date:  2015-05-12       Impact factor: 2.260

Review 2.  Black-Box Gastrointestinal Tract-Needs and  Prospects of Gaining Insights of Fate of Fat, Protein,  and Starch in Case of Exocrine Pancreatic  Insufficiency by Using Fistulated Pigs.

Authors:  Anne Mößeler; Josef Kamphues
Journal:  Nutrients       Date:  2017-02-16       Impact factor: 5.717

3.  Long term follow-up of a simplified and less burdened pancreatic duct ligation model of exocrine pancreatic insufficiency in Goettingen Minipigs.

Authors:  Andreas Minh Luu; Alexander Brock; Sabrina Ritz; Sandra Junghänel; Ingo Aldag; Stella Edskes; Marcus Hartmann; Michael Hessler; Michael Praktiknjo; Philip Arnemann; Christian Ertmer; Waldemar Uhl; Juergen Schnekenburger; Torsten Herzog
Journal:  BMC Gastroenterol       Date:  2020-11-30       Impact factor: 3.067

4.  Gut microbiome as a response marker for pancreatic enzyme replacement therapy in a porcine model of exocrine pancreas insufficiency.

Authors:  Sabrina Ritz; Daniela Hahn; Haleluya T Wami; Karin Tegelkamp; Ulrich Dobrindt; Juergen Schnekenburger
Journal:  Microb Cell Fact       Date:  2020-12-03       Impact factor: 5.328

5.  Responses of Ileal and Fecal Microbiota to Withdrawal of Pancreatic Enzyme Replacement Therapy in a Porcine Model of Exocrine Pancreatic Insufficiency.

Authors:  Julia Hankel; Anne Mößeler; Clara Berenike Hartung; Silke Rath; Lisa Schulten; Christian Visscher; Josef Kamphues; Marius Vital
Journal:  Int J Mol Sci       Date:  2022-10-02       Impact factor: 6.208

6.  Oral Supplementation with a Special Additive of Retinyl Palmitate and Alpha Tocopherol Reduces Growth Retardation in Young Pancreatic Duct Ligated Pigs Used as a Model for Children Suffering from Exocrine Pancreatic Insufficiency.

Authors:  Anne Mößeler; Marion Schmicke; Martin Höltershinken; Martin Beyerbach; Josef Kamphues
Journal:  Int J Mol Sci       Date:  2016-09-28       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.